Madrigal Pharmaceuticals, Inc.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs applyAbout MDGL
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Buy US stocks in Australia starting with MDGL. Open an account and start investing today!
$6.04B
-
0.00%
167.77K
$289.91
$276.63
$287.67
$299.98
$119.76
Ready to start your investing journey with Stake?
Open an accountMDGL FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in MDGL
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MDGL
on Stake
Buy MDGL from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of MDGL from only US$10 with fractional shares
![Canstar award phone](/_next/image?url=%2Fimages%2Fstocks%2Fsidebar_phone_4x.png&w=3840&q=75)